Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7120655 | 0.84 | TSHR (0.31) | — | |
| SCHEMBL5064896 | 0.82 | GRM2 (0.31) | ALOX15 | |
| SCHEMBL218875 | 0.82 | GRM2 (0.31) | ALOX15 | |
| SCHEMBL4247811 | 0.81 | OPRM1 (0.33) | — | |
| Hydrochloric Acid SCHEMBL471787 | 0.80 | — | — | |
| SCHEMBL9094889 | 0.80 | — | — | |
| SCHEMBL5961836 | 0.79 | — | — | |
| SCHEMBL7157746 | 0.77 | — | — | |
| SCHEMBL7056473 | 0.76 | — | — | |
| SCHEMBL8876149 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7645443-B2 | Polyether-based composition curable by metathesis reaction | KERR CORPORATION (US) | 2010-01-12 | — | — | US | disclosed |
| EP-1820813-A1 | Polyether-based composition curable by metathesis reaction | Kerr Corporation (US) | 2007-08-22 | — | — | EP | disclosed |
| US-20060171900-A1 | POLYETHER-BASED COMPOSITION CURABLE BY METATHESIS REACTION | KERR CORPORATION (US) | 2006-08-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060171900-A1 | POLYETHER-BASED COMPOSITION CURABLE BY METATHESIS REACTION | TIPRL, RER1, REV1 | ALOX15 1744/4885GAA 3775/4885CTNNB1 4409/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.